NEW YORK (MedscapeWire) Apr 08 — A "promising" new treatment may prevent delayed vasospasm, a dreaded and often fatal complication after subarachnoid hemorrhage (SAH). Preliminary results with ...
Please provide your email address to receive an email when new articles are posted on . Moderate to severe angiographic vasospasm was detected more often in controls than in those given implants. At ...
Dallas, TX - Japanese researchers report that prolonged release implants containing the calcium channel blocker nicardipine "completely" prevented vasospasm in 20 patients after aneurysmal ...
YOKNEAM, Israel & MIAMI--(BUSINESS WIRE)--Rapid Medical, a leading developer of advanced neurovascular devices, today announced FDA breakthrough designation for its Comaneci™ embolization assist ...
A new review published in the Journal of Intensive Medicine on 25 July, 2025 and led by Dr. Alice Jacquens and Dr. Clara Perrault from Pitié Salpêtrière Hospital, Paris, France, sheds light on an ...
In patients with angina and no obstructive coronary artery disease (ANOCA), coronary vasospasm elicited by acetylcholine, regardless of phenotype, is associated with more-advanced atherosclerosis, ...
Cerebral vasospasm is a major cause of morbidity and mortality following aneurysmal subarachnoid hemorrhage (SAH). A recent randomized clinical trial in the US has investigated the ability of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results